SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-039841
Filing Date
2019-11-04
Accepted
2019-11-04 16:46:32
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-10q_20190930.htm 10-Q 2851631
2 EX-31.1 arvn-ex311_13.htm EX-31.1 18201
3 EX-31.2 arvn-ex312_8.htm EX-31.2 18172
4 EX-32.1 arvn-ex321_11.htm EX-32.1 9220
5 EX-32.2 arvn-ex322_15.htm EX-32.2 9222
  Complete submission text file 0001564590-19-039841.txt   7532008

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arvn-20190930.xml EX-101.INS 1206176
7 XBRL TAXONOMY EXTENSION SCHEMA arvn-20190930.xsd EX-101.SCH 59681
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20190930_cal.xml EX-101.CAL 50806
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20190930_def.xml EX-101.DEF 213774
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20190930_lab.xml EX-101.LAB 459688
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20190930_pre.xml EX-101.PRE 360997
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 191190450
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences